Pharma’s Blind Spot: How AI Citation Sources Are Reshaping Drug Brand Risk
When a patient asks ChatGPT whether Ozempic causes pancreatitis, the answer they receive depends entirely on which sources the model […]
When a patient asks ChatGPT whether Ozempic causes pancreatitis, the answer they receive depends entirely on which sources the model […]
A patient with rheumatoid arthritis does not always call her rheumatologist first anymore. She opens ChatGPT and asks whether switching
Artificial intelligence is beginning to change not only how patients search for information about medicines, but also how journalists research
A patient asks ChatGPT if it is safe to skip a dose of a heart medication because they feel dizzy.
In 2023, a 54-year-old woman in Phoenix typed a question into ChatGPT that her endocrinologist hadn’t fully answered to her
When a physician in Ohio types “best GLP-1 for weight loss” into Perplexity and receives a two-paragraph synthesis with no
ChatGPT has told patients that Ozempic is FDA-approved for weight loss in children. Gemini has cited drug interaction warnings that
Somewhere between the formulary decision and the first filled prescription, a patient opens ChatGPT and asks: “Is Ozempic safe for
A physician types “best GLP-1 for weight loss” into ChatGPT. A patient asks Claude which SGLT2 inhibitor has the fewest
When a patient types ‘Can I take Ozempic if I have pancreatitis?’ into ChatGPT at 11 p.m., they are not
A patient types ‘Can I take Ozempic and metformin together?’ into ChatGPT. A physician asks Gemini about semaglutide dosing for
Somewhere between medical affairs, pharmacovigilance, digital marketing, and IT, there is a gap large enough to swallow a drug brand.
Sign in or create a free account to read this DrugChatter article